Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$16.4M
+13.5% from 2023
Prescriptions
641
$25,655.61 per claim
Patients
62
79 prescribers
Total spending, 2024
$16.4M
$265,245.95 per patient
Medicare prescription drug plans paid $16.4M for Symdeko in 2024, for 641 prescriptions and refills to 62 patients (up 13.5% from 2023). The average cost per claim was $25,655.61.
California had the highest Medicare cost for Symdeko in 2024: $2.0M for 79 claims, followed by North Carolina ($1.3M).
Meredith N Wiltsie, nurse practitioner in Stanford, CA, had the highest Medicare cost for Symdeko in 2024: 34 claims costing $880K.
Symdeko is made by Vertex Pharmaceuticals Incorporated (VRTX), listed in the Medicare spending data as Vertex Pharmace.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Meredith N Wiltsie Stanford, CA | Nurse Practitioner | 34 | Under 11 | $880K |
| Theresa R Heynekamp Albuquerque, NM | Pulmonary Disease | 21 | Under 11 | $527K |
| Robert R Kempainen |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 77 | 501 | 65 | $13.2M |
| 2023 | 79 | 529 | 71 | $14.5M |
| 2024 | 79 | 641 | 62 | $16.4M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Critical Care (Intensivists) |
| 18 |
| Under 11 |
| $464K |
| Samantha Kane Philadelphia, PA | Nurse Practitioner | 14 | Under 11 | $454K |
| Jerry A Nick Denver, CO | Pulmonary Disease | 14 | Under 11 | $395K |
| Abraham Rotbart Aventura, FL | Internal Medicine | 15 | Under 11 | $375K |
| Lisa Paul Valhalla, NY | Pulmonary Disease | 13 | Under 11 | $367K |
| Jagadish M Patil Minneapolis, MN | Critical Care (Intensivists) | 14 | Under 11 | $362K |
| Jessica C Farrell Houston, TX | Nurse Practitioner | 14 | Under 11 | $355K |
| Alexander R Graham Durham, NC | Pulmonary Disease | 14 | Under 11 | $352K |
| Bryon D Quick Oakland, CA | Internal Medicine | 14 | Under 11 | $350K |
| Diane R Pearl Nantucket, MA | Family Practice | 12 | Under 11 | $340K |
| Jennifer L Taylor-Cousar Denver, CO | Pulmonary Disease | 13 | Under 11 | $334K |
| Laura Beth Gifford Chapel Hill, NC | Physician Assistant | 13 | Under 11 | $330K |
| Subhashini A Sellers Chapel Hill, NC | Pulmonary Disease | 13 | Under 11 | $330K |
| Zachary M Holliday Columbia, MO | Critical Care (Intensivists) | 14 | Under 11 | $326K |
| Sunjay R Devarajan Houston, TX | Pulmonary Disease | 12 | Under 11 | $305K |
| Theodore G Liou Salt Lake City, UT | Pulmonary Disease | 12 | Under 11 | $292K |
| Annette A Su Stanford, CA | Nurse Practitioner | 12 | Under 11 | $286K |
| Carla Brutus Hollywood, FL | Nurse Practitioner | 11 | Under 11 | $279K |
| Rose A Franco Milwaukee, WI | Pulmonary Disease | 12 | Under 11 | $265K |
| Gopal Allada Portland, OR | Pulmonary Disease | 12 | Under 11 | $264K |
| Douglas P Lewis Wichita, KS | Family Practice | 11 | Under 11 | $261K |
| Holly J Carveth Salt Lake City, UT | Pulmonary Disease | 12 | Under 11 | $259K |
| Kapilkumar N Patel Winston Salem, NC | Pulmonary Disease | 11 | Under 11 | $257K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Vertex Pharmace VRTX | 641 | $16.4M |